Article thumbnail

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients

By N Knijn, L J M Mekenkamp, M Klomp, M E Vink-Börger, J Tol, S Teerenstra, J W R Meijer, M Tebar, S Riemersma, J H J M van Krieken, C J A Punt and I D Nagtegaal
Topics: Molecular Diagnostics
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:3065268
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1991). Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver.
  2. (1988). Genetic alterations during colorectal-tumor development.
  3. (1998). Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
  4. (2009). KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis. PLoS One 4: e8199 De Roock
  5. (2010). Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Clin Ther 32: 437–453 Van Cutsem
  6. (1992). Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer 28A: 1115–1120 Loupakis